A: Insulin B chain,Insulin A chain B: Insulin B chain,Insulin A chain C: Insulin B chain,Insulin A chain D: Insulin B chain,Insulin A chain E: Insulin B chain,Insulin A chain F: Insulin B chain,Insulin A chain ヘテロ分子
Component-ID: 1 / Ens-ID: 1 / Beg auth comp-ID: PHE / Beg label comp-ID: PHE / End auth comp-ID: ASN / End label comp-ID: ASN / Auth seq-ID: 1 - 49 / Label seq-ID: 1 - 49
Dom-ID
Selection details
Auth asym-ID
Label asym-ID
1
chainA
A
A
2
chainB
B
B
3
chainC
C
C
4
chainD
D
D
5
chainE
E
E
6
chainF
F
F
-
要素
#1: タンパク質・ペプチド
InsulinBchain,InsulinAchain
分子量: 5601.417 Da / 分子数: 6 変異: Residues corresponding to B chain amino acids 29-30 were deleted, and Pro-28 was mutated to Lys. This, in effect, is the equivalent of deleting only residues 28 and 30 of the wild-type B chain. 由来タイプ: 合成 詳細: This is a fusion protein consisting of a mutant insulin B chain followed by the insulin A chain. Six of these fusion chains are in the asymmetric unit 由来: (合成) Homo sapiens (ヒト) / 参照: UniProt: P01308
This construct contains a mutant of the naturally occurring insulin B chain and the wild-type ...This construct contains a mutant of the naturally occurring insulin B chain and the wild-type naturally occurring A chain fused together into one peptide chain.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 1.96 Å3/Da / 溶媒含有率: 37.11 %
結晶化
温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 詳細: 1:2.5 ratio of Zn2+ to protein monomer in 0.02M Tris-HCl, 0.05M sodium citrate, 5% acetone, 0.03% phenol, 0.01% zinc acetate, PH 8.0